Skip to Main Content

Paper Details

Impact of the hepatoselective glucokinase activator TTP399 on ketoacidosis during insulin withdrawal in people with type 1 diabetes.
Diabetes Obes Metab
3
2022
Author NameAffiliation
Klara R KleinUniversity of North Carolina School of Medicine
John B BuseUniversity of North Carolina School of Medicine
  • 1 - 2

Datasets

Release 1.2